HUP0201625A2 - Pharmaceutical composition containing calcium valproate with delayed active substance release and method for the producing of said composition - Google Patents

Pharmaceutical composition containing calcium valproate with delayed active substance release and method for the producing of said composition

Info

Publication number
HUP0201625A2
HUP0201625A2 HU0201625A HUP0201625A HUP0201625A2 HU P0201625 A2 HUP0201625 A2 HU P0201625A2 HU 0201625 A HU0201625 A HU 0201625A HU P0201625 A HUP0201625 A HU P0201625A HU P0201625 A2 HUP0201625 A2 HU P0201625A2
Authority
HU
Hungary
Prior art keywords
producing
active substance
containing calcium
pharmaceutical composition
substance release
Prior art date
Application number
HU0201625A
Other languages
Hungarian (hu)
Inventor
Ramona Dieckmann
Dagmar GOEBEL
Evelyn Heuberger-Wieland
Michael Pieroth
Bernd Terhaag
Original Assignee
Awd Pharma Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Awd Pharma Gmbh & Co Kg filed Critical Awd Pharma Gmbh & Co Kg
Publication of HUP0201625A2 publication Critical patent/HUP0201625A2/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HU0201625A 1998-09-03 1999-09-03 Pharmaceutical composition containing calcium valproate with delayed active substance release and method for the producing of said composition HUP0201625A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19840152A DE19840152A1 (en) 1998-09-03 1998-09-03 Pharmaceutical compositions containing calcium valproate with a delayed release of active substance, process for their preparation and their use

Publications (1)

Publication Number Publication Date
HUP0201625A2 true HUP0201625A2 (en) 2002-09-28

Family

ID=7879672

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0201625A HUP0201625A2 (en) 1998-09-03 1999-09-03 Pharmaceutical composition containing calcium valproate with delayed active substance release and method for the producing of said composition

Country Status (12)

Country Link
US (1) US20020052411A1 (en)
EP (1) EP1107792A1 (en)
AU (1) AU5859799A (en)
BG (1) BG105276A (en)
CZ (1) CZ2001753A3 (en)
DE (1) DE19840152A1 (en)
EA (1) EA002695B1 (en)
HU (1) HUP0201625A2 (en)
NO (1) NO20011087L (en)
PL (1) PL346474A1 (en)
SK (1) SK2592001A3 (en)
WO (1) WO2000013711A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EE200200504A (en) * 2000-03-08 2004-02-16 Awd.Pharma Gmbh & Co. Kg Pharmaceutical preparations
US7456306B2 (en) * 2003-07-28 2008-11-25 Mallinckrodt Inc Stearate composition and method of production thereof
RU2008113439A (en) * 2005-09-09 2009-10-20 Лабофарм Инк. (CA) COMPOSITIONS WITH SLOW DELIVERY OF A MEDICINAL PRODUCT
US20070160960A1 (en) * 2005-10-21 2007-07-12 Laser Shot, Inc. System and method for calculating a projectile impact coordinates
US20090111733A1 (en) * 2006-07-19 2009-04-30 President And Fellows Of Harvard College Par-4 related methods and compositions

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3063328D1 (en) * 1979-08-20 1983-07-07 Abbott Lab Mixed salt of valproic acid
IL72381A (en) * 1983-07-20 1988-03-31 Sanofi Sa Pharmaceutical composition based on valproic acid
CA1242738A (en) * 1983-10-26 1988-10-04 Abbott Laboratories Acid salts of valproic acid
NL8600050A (en) * 1986-01-13 1987-08-03 Sanico Nv PHARMACEUTICAL PREPARATION WITH DELAYED DELIVERY OF THE ACTIVE SUBSTANCE AND METHOD FOR PREPARING IT.
JPS63101320A (en) * 1986-10-17 1988-05-06 Dainippon Pharmaceut Co Ltd Calcium valproate preparation
DE3709230A1 (en) * 1987-03-20 1988-10-06 Desitin Arzneimittel Gmbh NEW VALPROINIC ACID CALCIUM
DD295543A5 (en) * 1987-11-26 1991-11-07 Univ Halle Wittenberg METHOD FOR PRODUCING A CA VALPROAT DRUG FILM WITH SIMILARLY DELAYED ACTIVE INGREDIENT EXTRACTION
FR2643556B1 (en) * 1989-02-27 1993-03-05 Sanofi Sa PHARMACEUTICAL COMPOSITION WITH SUSTAINED RELEASE OF VALPROIC ACID
US6287598B1 (en) * 1993-05-28 2001-09-11 Alza Corporation Method for providing sustained antiepileptic therapy

Also Published As

Publication number Publication date
PL346474A1 (en) 2002-02-11
NO20011087L (en) 2001-05-02
BG105276A (en) 2001-11-30
DE19840152A1 (en) 2000-03-09
EA200100309A1 (en) 2001-08-27
AU5859799A (en) 2000-03-27
WO2000013711A1 (en) 2000-03-16
SK2592001A3 (en) 2001-11-06
EA002695B1 (en) 2002-08-29
EP1107792A1 (en) 2001-06-20
CZ2001753A3 (en) 2001-08-15
US20020052411A1 (en) 2002-05-02
NO20011087D0 (en) 2001-03-02

Similar Documents

Publication Publication Date Title
HUP0000808A3 (en) Pharmaceutical composition of fenofibrate and method for preparing same
HUP0202338A2 (en) Pharmaceutical composition containing fenofibrate and preparation method
HK1151462A1 (en) Implants for administering substances and methods of producing implants
HUP0103621A3 (en) Fentanyl composition for the treatment of acute pain
HUP0301325A3 (en) Stabilized pharmaceutically effective composition and pharmaceutical composition comprising the same and process for preparation the composition
EP0858334A4 (en) Analgesic immediate and controlled release pharmaceutical composition
PL336296A1 (en) Composition of retarded active substance release and method of obtaining them
GB9727048D0 (en) Process for the preparation of magnesium and carbonate substituted hydroxyapatite
ZA971869B (en) Implants with phasewise release of pharmaceutical substance.
IL141081A0 (en) Use of biogenic estrogen sulfamates for the production of pharmaceutical compositions and pharmaceutical compositions containing biogenic estrogen sulfamates
HUP0104985A3 (en) Pharmaceutical levothyroxine compositions and process for their preparation
HUP9700806A3 (en) Matrix tablet allowing the prolonged release of the sodium salt of tianeptine and process for the preparation thereof
IL145126A0 (en) Process for the preparation of discrete particles of calcium carbonate
IL142561A0 (en) Controlled release fertilizer compositions and processes for the preparation thereof
HUP0201625A2 (en) Pharmaceutical composition containing calcium valproate with delayed active substance release and method for the producing of said composition
HUP0103826A3 (en) A process for the preparation of zofenopril calcium salt and medicament containing it and its use
HUP0004033A3 (en) Controlled release fertilizer compositions and processes for the preparation thereof
HUP0104544A3 (en) New pharmaceutical composition and the process for its preparation
HU9800369D0 (en) Pellet-based pharmaceutical composition of controlled release with high content of potassium-chloride, and process for it's production
GB9606579D0 (en) Pharmaceutical composition and methods for the manufacture thereof
HUP0102002A3 (en) Biologically active composition and process for its preparation
IL129180A0 (en) Method and pharmaceutical composition for wound healing
ZA987799B (en) Pharmaceutical compositions for the controlled release of active substances
HU9801499D0 (en) Pharmaceutical composition of methastasis-inhibiting activity and process for producing the composition
LT98168A (en) Method and composition for the preparation of honey cake